Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Innovation Adoption Is Key UK Challenge Says MedTech Directorate

Standing still is not an option if the health care system is to remain sustainable

Executive Summary

The UK’s MedTech Directorate is pressing ahead with 16 separate initiatives under its recently issued medtech strategy. It all adds to the sense that 2023 will be a major year for UK medtech.

You may also be interested in...



UK Pro-Innovation Report Offers Promise For Medtech With MHRA/NICE Alignment

Report to government underlines need for faster, parallel evaluation of medtech and healthtech innovation and recommends bigger role for MHRA alongside work done by approved bodies on UKCA file processing.

UK Diagnostics Companies Count On Medtech Strategy To Deliver

The UK government’s first ever medtech strategy has received plaudits for its ambition. The diagnostics industry, while supportive of the intent, is waiting for more than just promises.

UK Updates Guidance To Reflect EU Medtech Extensions - Pledges Focus On Agility, Innovation

The EU’s decision to extend the Medical Device Regulation transition periods for legacy medical device directives products will be mirrored in the UK, which also continues to evolve its post-Brexit medtech regulatory system.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT147716

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel